RGCIRC conducts a two-day conference on breast cancer care

RGCIRC hosted the “Breast Cancer Update Conference 2024,” focusing on new cancer treatment advancements. Renowned oncologists discussed targeted therapies, immunotherapy, and precision medicine like Pembrolizumab. Dr. D C Doval highlighted the event’s role in knowledge exchange and revolutionary changes in breast cancer management. Panel discussions covered early-stage, metastatic breast cancer, emphasizing immunotherapy’s evolving role. The conference underscored RGCIRC’s commitment to advancing clinical practices through global research integration.